secwatch.observer — SEC 8-K summary
======================================

Issuer:     Co-Diagnostics, Inc. (CODX)
CIK:        0001692415
Form:       8-K
Filed at:   2025-03-27T23:59:59+00:00
Accession:  0001641172-25-000922
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Co-Diagnostics FY2024 revenue $3.9M, net loss $37.6M; withdraws 510(k) for platform
--------------------------------------------------------------------------------

- Revenue $3.9M vs $6.8M in 2023; product revenue $0.8M, grant revenue $3.1M.
- Net loss $37.6M ($1.24/diluted share) vs $35.3M ($1.20) prior year.
- Adjusted EBITDA loss of $33.5M; operating expenses $43.0M decreased 5.2% YoY.
- Cash and marketable securities $29.7M as of Dec 31, 2024.
- Withdrew initial 510(k) for Co-Dx PCR Pro; plans to resubmit enhanced version.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1692415/000164117225000922/0001641172-25-000922-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1692415/000164117225000922/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-000922

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer